Monday, 27 January 2020

Japan News

  • Takeda R&D filed 7 NDAs in the last 8 months

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven new drug applications (NDAs) during the past eight months in several A...Read more

  • US FDA's Priority Review Status for Takeda's IND

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

    Singapore: Takeda Pharmaceutical and its wholly-owned subsidiary, Takeda Pharmaceuticals USA, have announced that the US Food and Drug Administration (FDA) has granted Priority Review statu...Read more

  • India invites Japanese firms to invest in healthcare

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Oct, 2013

    New Delhi: Aiming at becoming one of the global manufacturing hubs, besides being a large healthcare market, India has invited Japanese companies to invest in country's healthcare sector, a...Read more

  • BS Survey: Healthcare is getting smarter in Asia

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    ...Read more

  • Japan's top 5 bio firms fund $100 mn HIV, TB research

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

    Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come together to initiate an effort worth $100 million to tackle HIV, malaria,...Read more

  • Eisai gets WHO prequalification, will donate 2.2 bn doses

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of elephantiasis, and the Japanese firm has committed to donate 2.2 billio...Read more

  • BSA-CMR Survey: APAC CROs stick to an average of 50 clients

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Sysmex wins performance award in the US

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: The wholly-owned US subsidiary of Sysmex, Sysmex America, has won the seventh annual Pinnacle Award presented by the Premier healthcare alliance. Japan-based Sysmex is a global l...Read more

  • Solasia appoints Yoshihiro Arai as president

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

    Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to president and representative director of the company. Current Chief ...Read more

  • New medtech market infographic published

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting article titled 'The Asia-Pacific medtech market will grow 10 percent over...Read more

  • Thomson Reuters to restore Tohoku to pre-earthquake state

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2013

    Singapore: The intellectual property and science business of Thomson Reuters has collaborated with Japan's Tohoku University and Tohoku Medical Megabank Organization (ToMMo) to help restore...Read more

  • Proteus, Otsuka to collaborate on new medicines

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: Proteus Digital Health and Otsuka Pharmaceutical, a subsidiary of Japan-headquartered Otsuka Group, have entered into an exclusive worldwide license and collaboration agreement t...Read more

  • Lonza, BioWa sign research agreements with Pfizer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko Kogyo, have entered into research agreements with Pfizer, allowing th...Read more

  • FDA recommends Takeda's drug for Chrohn's disease

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States (U.S.) Food and Drug Administration (FDA) ha...Read more

  • Harlan Japan appoints Hiroharu Okochi as president

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: Harlan Contract Research Services (CRS), a division of Harlan Laboratories, a privately held provider of general and specialty toxicology services to the global chemical, agroche...Read more

  • Accuray to expand services in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Singapore: Accuray, a radiation oncology company, has extended its industry-leading Emerald Service Program for the TomoTherapy System, which provides equipment protection and product updat...Read more

  • What services do APAC CROs offer to their clients?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Shionogi partners with six Irish universities

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for an R&D partnership with six Irish universities, under the compan...Read more



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls